Paid Clinical Trials in East Brunswick, NJ

As of September 2026, 69 paid clinical trials are recruiting in East Brunswick, New Jersey. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 24, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

67 clinical trials

Get a weekly email when new trials open in East Brunswick, NJ.

Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

for Pancreatic Cancer

Sites in East Brunswick, New Brunswick +7 more locations

Sponsor: Revolution Medicines, Inc.

Sex: All·Age: 18+

Code: NCT07621718·Phase 3·Recruiting·Listed Jun 2026

Apply to this trial

Study of GS-2426 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in East Brunswick +3 more locations

Sponsor: Gilead Sciences

Sex: All·Age: 18+

Code: NCT07601243·Phase 1·Recruiting·Listed May 2026

Apply to this trial

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

for Colorectal Cancer

Drug: Bevacizumab

Sites in East Brunswick +16 more locations

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT07525206·Phase 3·Recruiting·Listed Apr 2026

Apply to this trial

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

for Epidermal Growth Factor

Sites in East Brunswick +5 more locations

Sponsor: EpiBiologics

Sex: All·Age: 18+

Code: NCT07462377·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer

for Breast Cancer

Sites in East Brunswick +3 more locations

Sponsor: Hoffmann-La Roche

Sex: All·Age: 18+

Code: NCT07368998·Phase 2·Recruiting·Listed Jan 2026

Apply to this trial

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

for PIK3CA Mutations

Sites in East Brunswick +10 more locations

Sponsor: Cogent Biosciences, Inc.

Sex: All·Age: 18+

Code: NCT07383506·Phase 1·Recruiting·Listed Feb 2026

Apply to this trial

A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors

for Solid Tumors, Adult

Sites in East Brunswick +7 more locations

Sponsor: Hutchmed

Sex: All·Age: 18+

Code: NCT07228247·Phase 1, Phase 2·Recruiting·Listed Nov 2025

Apply to this trial

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

for Ovarian Cancer

Sites in East Brunswick +19 more locations

Sponsor: Tubulis GmbH

Sex: All·Age: 18+

Code: NCT06303505·Phase 1, Phase 2·Recruiting·Listed Mar 2024

Apply to this trial

Visugromab in Cachexia International Trial

for Cancer-associated Cachexia

Sites in East Brunswick +9 more locations

Sponsor: CatalYm GmbH

Sex: All·Age: 18+

Code: NCT07112196·Phase 2, Phase 3·Recruiting·Listed Aug 2025

Apply to this trial

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

for Advanced or Metastatic Solid Tumor

Sites in East Brunswick +10 more locations

Sponsor: Pliant Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06270706·Phase 1·Recruiting·Listed Feb 2024

Apply to this trial

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

for Prostate Cancer Castration-resistant Prostate Cancer

Sites in East Brunswick +6 more locations

Sponsor: MBrace Therapeutics

Sex: All·Age: 18+

Code: NCT07145255·Phase 1, Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

Behavioral Exposure for Introceptive Tolerance RCT

for Exercise Sensitivity

Sites in East Brunswick, New Brunswick & Hillsborough

Sponsor: Rutgers, The State University of New Jersey

Sex: All·Age: 40+

Code: NCT05398276·Recruiting·Listed May 2022

Apply to this trial

A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

for Metastatic Castration Resistant Prostate Cancer

Sites in East Brunswick +9 more locations

Sponsor: Flare Therapeutics Inc.

Sex: Male·Age: 18+

Code: NCT07719361·Phase 1·Recruiting·Listed Jul 2026

Apply to this trial

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

for Non-Small Cell Lung Cancer

Sites in East Brunswick +11 more locations

Sponsor: Verastem, Inc.

Sex: All·Age: 18+

Code: NCT07659782·Phase 2·Recruiting·Listed Jun 2026

Apply to this trial

BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

for Small Cell Lung Cancer Extensive Stage

Drug: Atezolizumab

Sites in East Brunswick +6 more locations

Sponsor: SystImmune Inc.

Sex: All·Age: 18+

Code: NCT07625644·Phase 3·Recruiting·Listed Jun 2026

Apply to this trial

First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer

for Metastatic Prostate Cancer

Sites in East Brunswick, Hackensack +2 more locations

Sponsor: AstraZeneca

Sex: Male·Age: 18 - 100

Code: NCT07529717·Phase 1, Phase 2·Recruiting·Listed Apr 2026

Apply to this trial

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

for Gastric Cancer

Drug: Sonesitatug vedotin

Sites in East Brunswick, New Brunswick +78 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07431281·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive

for HER2-positive Breast Cancer

Sites in East Brunswick +3 more locations

Sponsor: Hoffmann-La Roche

Sex: All·Age: 18+

Code: NCT07413939·Phase 2, Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

for Relapsed/Refractory Hematological Malignancies

Sites in East Brunswick +4 more locations

Sponsor: Ascentage Pharma Group Inc.

Sex: All·Age: 18+

Code: NCT07424833·Phase 1·Recruiting·Listed Feb 2026

Apply to this trial

Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

for Adenocarcinoma

Drug: Relacorilant

Sites in East Brunswick, Morristown +13 more locations

Sponsor: Corcept Therapeutics

Sex: All·Age: 18+

Code: NCT07259317·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer

for Neoplasms, Prostate

Sites in East Brunswick +5 more locations

Sponsor: GlaxoSmithKline

Sex: Male·Age: 18+

Code: NCT06990880·Phase 1, Phase 2·Recruiting·Listed May 2025

Apply to this trial

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

for Endometrial Cancer

Sites in East Brunswick +10 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT05489211·Phase 2·Recruiting·Listed Aug 2022

Apply to this trial